Nov 2, 2017
Top Pharma News | October - November 2017
Amgen And CytomX Therapeutics Announce Strategic Collaboration in Immuno-Oncology
October 3, 2017
Amgen and CytomX Therapeutics, Inc. have announced that the companies have entered into a strategic collaboration in immuno-oncology. The companies will co-develop a CytomX Probody™ T-cell engaging bispecific against the Epidermal Growth Factor Receptor (EGFR), a highly validated oncology target…
View On WordPress
#AbbVie#Alecensa#Allergan#ALUNBRIGTM#AMGen#Anti-virals#apalutamide#AstraZeneca#AVYCAZ#Boston Children&039;s Hospital#Bristol-Myers Squibb#Cancer Drugs#cobas#CYRAMZA#CytomX Probody#CytomX Therapeutics#Eli Lilly and Company#Flexion Therapeutics#Forecasting#Imfinzi#IMLYGIC#INVOKANA#Janssen#lorlatinib#Lyrica#NAVIFY Tumor Board#Opdivo#PARP Inhibitors#Pfizer#Prolia